Ameliorating Cardiovascular Risk in Patients with Type 2 Diabetes

被引：3
|
作者：
Motairek, Issam [1 ]
Al-Kindi, Sadeer [1 ]
机构：
[1] Case Western Reserve Univ, Univ Hosp Harrington Heart & Vasc Inst, Sch Med, 11100 Euclid Ave, Cleveland, OH 44106 USA
来源：
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2023年 / 52卷 / 01期
关键词：
Cardiovascular disease; Type 2 diabetes mellitus; Risk factors; PRIMARY PREVENTION; GLYCEMIC CONTROL; DISEASE; OUTCOMES; THERAPY; ADULTS; INTERVENTIONS; COMPLICATIONS; METAANALYSIS; ASSOCIATION;
D O I：
10.1016/j.ecl.2022.07.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：135 / 147
页数：13
相关论文
共 50 条
  • [21] Cardiovascular disease risk communication for patients with type 2 diabetes: The @RISK Study
    Welschen, L. M. C.
    Bot, S. D. M.
    van der Weijden, T.
    Timmermans, D. R. M.
    Dekker, J. M.
    Nijpels, G.
    DIABETOLOGIA, 2010, 53
  • [22] Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes
    Schernthaner, Guntram
    Jarvis, Sarah
    Lotan, Chaim
    Prazny, Martin
    Wanner, Christoph
    Wascher, Thomas C.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 69 - 79
  • [23] Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
    Inzucchi, Silvio E.
    Wanner, Christoph
    Lachin, John M.
    Fitchett, David
    Bluhmki, Erich
    Hantel, Stefan
    Mattheus, Michaela
    Devins, Theresa
    Johansen, Odd Erik
    Woerle, Hans Juergen
    Broedl, Uli C.
    Zinman, Bernard
    CIRCULATION, 2015, 132 (23) : 2271 - 2271
  • [24] Cardiovascular risk factors in patients of type 2 diabetes mellitus with and without cardiovascular complications
    Aasvee, KE
    Kurvinen, E
    Roovere, T
    Tupits, H
    Hedman, A
    Jauhiainen, M
    Sundvall, J
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 152 - 152
  • [25] Cardiovascular risk in patients with newly diagnosed type 2 diabetes mellitus
    Fuadal-Saraj
    McAteer, S
    Galvin, J
    Keelan, E
    Fitzgerald, D
    Cawood, T
    Sreenan, SK
    DIABETES, 2005, 54 : A172 - A172
  • [26] Cardiovascular Risk Mitigation in Type 2 Diabetes Patients Treated with Liraglutide
    F-Marinno, Alexis
    A-Troncoso, Isabel
    Carollo-Limeres, C.
    Cadarso-Suarez, C.
    DIABETES, 2014, 63 : A257 - A257
  • [27] Reducing cardiovascular risk in patients with type 2 diabetes: management of dyslipidemia
    Campbell, Jennifer
    Hilleman, Daniel
    FORMULARY, 2010, 45 (04) : 124 - 134
  • [28] Prevention of cardiovascular risk in patients with type 2 diabetes mellitus with aspirin
    Duly-Bouhanick, B
    Menard, S
    Hadjadj, S
    Soares-Barbosa, S
    Plun-Favreau, J
    Guilloteau, G
    PRESSE MEDICALE, 2001, 30 (02): : 87 - 91
  • [29] Predictor for cardiovascular risk in patients with type-2 diabetes mellitus
    Azharuddin, Md
    Kapur, Prem
    Mishra, Ritu
    Saleem, Shakir
    Gupta, Ashok Kumar
    Adil, Mohammad
    Sharma, Manju
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2021, 12
  • [30] Factors of cardiovascular risk in patients with type 2 diabetes and incipient nephropathy
    Nelaj, E.
    Gjata, M.
    Lilaj, I
    Burazeri, G.
    Sadiku, E.
    Collaku, L.
    Bare, O.
    Tase, M.
    HIPPOKRATIA, 2008, 12 (04) : 221 - 224
12345